|
|
| Challenging the Norm: Smaller Partners, Bigger Impact (Big is Bad Trigger) | In our outsourcing industry, it is never an easy decision to select a partner when trying to run complex sequential trials. The need to gain regulatory approval for the treatments you have dedicated yourself to providing, coupled with the need to find a capable, reliable, and fair Contract Research Organization is quite daunting. Discover how a smaller full-service partner may be better suited to see your study through. |
|
|
|
|
By Liz McGuire, Clarkston Consulting | The federal workforce reductions pose significant challenges for the life sciences industry, particularly for R&D, supply chain oversight, and industry workforce development. | |
|
|
|
|
|
| Controlled Substances In Clinical Trials | Article | By Rich Nelson, John Hufnagel, and Rachel Castro, PCI Pharma Services | Handling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies. |
|
|
|
|
.png){kind=logo}
